Silver Book Fact

During the first year of a community pharmacy services program in 2003 which included 256 diabetes patients who used scheduled consultations, clinical goal setting, monitoring and collaborative drug therapy management with physicians and referrals to diabetes educators, the total average health care costs per patient were $918 lower than projected for the first year of enrollment.

Garret, Daniel G., and Benjamin M. Bluml. Patient Self-Management Program for Diabetes: First-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2005; 45(2): 130-7. http://www.aphafoundation.org/sites/default/files/ckeditor/files/MP7-PSMP-Diabetes-JAPhA-Final%20Report.pdf

Reference

Title
Patient Self-Management Program for Diabetes: First-year clinical, humanistic, and economic outcomes
Publication
J Am Pharm Assoc
Publication Date
2005
Authors
Garret, Daniel G., and Benjamin M. Bluml
Volume & Issue
Volume 45, Issue 2
Pages
130-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Widespread use of diabetes prevention drugs that enhance insulin sensitivity could result in a 50% prevention of type 2 diabetes over a 10 to 15 year period.  
  • Due to innovation as well as other factors, the death rate in the U.S. from diabetes decreased by 3.9% in 2007 from 2006.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Blood Pressure Control in Patients with Diabetes
    Tight blood pressure control in type 2 diabetes patients reduced progression of DR by 34% and risk of deterioration by 47% after 9 years.  
  • Every additional dollar spent on screening and treating diabetic eye disease in type 2 diabetics on insulin has produced health gains valued at $36.